Skip to main content
MarketsSingle-sourceLowDeveloping
2.0

Rein Therapeutics, Inc. receives notice of delisting from exchange

Rein Therapeutics, Inc. filed an 8-K disclosing a notice of delisting or failure to satisfy continued listing standards. The specific exchange and the nature of the non-compliance remain unspecified in the filing summary, signaling potential financial or regulatory distress for the issuer.

SEC EDGAR 8-K Filings1 day agoUSengCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

Entities

country
Source

Related signals

8 found